Financhill
Back

Avantis All Equity Markets Value ETF Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Buy
78

AVGV
Avantis All Equity Markets Value ETF

Last Price:
$73.71
Seasonality Move:
0.94%
Buy
64

LYEL
Lyell Immunopharma, Inc.

Last Price:
$37.17
Seasonality Move:
-16.78%
Buy
78
Avantis All Equity Markets Value ETF (AVGV) is a Buy

Is Avantis All Equity Markets Value ETF a Buy, Sell or Hold?

  • The current Avantis All Equity Markets Value ETF [AVGV] share price is $73.73. The Score for AVGV is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • AVGV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AVGV Stock Price Chart

What is Avantis All Equity Markets Value ETF's stock price today?

  • The Avantis All Equity Markets Value ETF share price today is $73.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVGV is experiencing buying pressure, which is a positive indicator for future bullish movement.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.

AVGV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.7 Buy
Relative Strength Index (14 RSI): 61.09 Buy
Chaikin Money Flow: 23279 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.53 - 73.81) Buy
Bollinger Bands (100): (68.37 - 72.05) Buy

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.08 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: -97373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 32.35) Buy
Bollinger Bands (100): (10.77 - 23.75) Buy

AVGV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 73.59 Buy
20-day SMA: 72.86 Buy
50-day SMA: 71.31 Buy
200-day SMA: 66.4 Buy
8-day EMA: 73.36 Buy
20-day EMA: 72.78 Buy
50-day EMA: 71.62 Buy
200-day EMA: 67.68 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.51 Buy
20-day SMA: 28.33 Buy
50-day SMA: 21.67 Buy
200-day SMA: 13.52 Buy
8-day EMA: 33.02 Buy
20-day EMA: 28.99 Buy
50-day EMA: 23.45 Buy
200-day EMA: 17.42 Buy

Avantis All Equity Markets Value ETF Earnings Growth & AVGV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

Avantis All Equity Markets Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):